Candel Therapeutics (CADL) Short Interest Ratio & Short Volume $8.80 +0.17 (+1.97%) (As of 12/24/2024 05:10 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Candel Therapeutics Short Interest DataCandel Therapeutics (CADL) has a short interest of 2.18 million shares, representing 10.86% of the float (the number of shares available for trading by the public). This marks a 3.81% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.7, indicating that it would take 5.7 days of the average trading volume of 2.42 million shares to cover all short positions.Current Short Interest2,180,000 sharesPrevious Short Interest2,100,000 sharesChange Vs. Previous Month+3.81%Dollar Volume Sold Short$10.25 millionShort Interest Ratio5.7 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares32,476,000 sharesFloat Size20,080,000 sharesShort Percent of Float10.86%Today's Trading Volume1,099,940 sharesAverage Trading Volume2,424,880 sharesToday's Volume Vs. Average45% Short Selling Candel Therapeutics? Sign up to receive the latest short interest report for Candel Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCADL Short Interest Over TimeCADL Days to Cover Over TimeCADL Percentage of Float Shorted Over Time Ad DTI[PDF] The Opportunity in GoldCommodities expert, Geof Smith, insists that the supercycle on gold is just getting warmed up. In fact, even though gold looks like this since he initially called a major bull run 11 months ago… He’s still predicting it will be the TOP trade of 2025. His free eBook explains why You see, the last time gold launched into a supercycle like this it surged 536% The time before that was over 1,000%... That’s why Geof released this urgent guide to help you. Most people think they’ve missed out, but he thinks we’re at the very beginning of what could be the largest gold rally of our lifetimes. But, believe it or not, Geof doesn’t think you should just buy and hold precious metals. He’ll share more about his approach inside the eBook and it might surprise you.Tap here to read it Candel Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20242,180,000 shares $10.25 million +3.8%10.9%5.7 $4.70 11/15/20242,100,000 shares $7.98 million +18.0%10.5%6.3 $3.80 10/31/20241,780,000 shares $9.40 million +8.5%9.0%7 $5.28 10/15/20241,640,000 shares $9.76 million +3.1%8.5%6.6 $5.95 9/30/20241,590,000 shares $11.02 million -5.9%8.2%5.6 $6.93 9/15/20241,690,000 shares $11.85 million No Change8.7%4.5 $7.01 Get the Latest News and Ratings for CADL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/20241,690,000 shares $11.41 million +3.7%9.2%4.5 $6.75 8/15/20241,630,000 shares $8.77 million +10.1%8.9%3 $5.38 7/31/20241,480,000 shares $8.78 million +5.7%8.0%2.3 $5.93 7/15/20241,400,000 shares $9.27 million +38.6%7.6%1.8 $6.62 6/30/20241,010,000 shares $6.26 million -4.7%5.3%0.5 $6.20 6/15/20241,060,000 shares $7.73 million -31.6%5.6%0.2 $7.29 5/31/20241,550,000 shares $13.80 million +83.0%8.3%0.3 $8.90 5/15/2024846,800 shares $11.86 million -19.4%5.0%0.2 $14.00 4/30/20241,050,000 shares $7.40 million -48.3%6.7%0.2 $7.05 4/15/20242,030,000 shares $11.81 million +1,161.7%13.0%0.4 $5.82 3/31/2024160,900 shares $254,222.00 +9.2%1.0%0 $1.58 3/15/2024147,300 shares $220,950.00 -24.7%1.0%1.7 $1.50 2/29/2024195,600 shares $363,816.00 -30.4%1.3%0.3 $1.86 2/15/2024281,200 shares $489,288.00 +69.2%1.8%0.5 $1.74 1/31/2024166,200 shares $216,060.00 -10.9%1.1%0.3 $1.30 1/15/2024186,600 shares $248,178.00 -9.2%1.2%0.3 $1.33 12/31/2023205,400 shares $301,938.00 -54.9%1.3%0.4 $1.47 12/15/2023455,500 shares $610,370.00 +1,071.0%2.9%0.8 $1.34 11/30/202338,900 shares $34,971.10 -5.8%0.3%1.3 $0.90 11/15/202341,300 shares $40,350.10 -40.8%0.3%1.3 $0.98 10/31/202369,800 shares $62,813.02 -56.4%0.4%2.3 $0.90 10/15/2023159,900 shares $143,910.00 -0.8%1.0%7.2 $0.90 9/30/2023161,200 shares $148,304.00 +0.5%1.0%8.8 $0.92 9/15/2023160,400 shares $202,104.00 -2.1%1.0%8.2 $1.26 8/31/2023163,900 shares $199,958.00 +1.2%1.0%9 $1.22 8/15/2023162,000 shares $187,920.00 -5.9%1.0%8.3 $1.16 7/31/2023172,100 shares $185,868.00 +8.6%1.0%8.8 $1.08 7/15/2023158,500 shares $183,860.00 -4.4%1.0%7.2 $1.16 6/30/2023165,800 shares $208,908.00 +20.9%1.0%4.9 $1.26 6/15/2023137,200 shares $196,196.00 +9.8%0.8%4.3 $1.43 5/31/2023125,000 shares $188,750.00 -7.3%0.8%3.9 $1.51 5/15/2023134,800 shares $215,680.00 +0.2%0.8%4.4 $1.60 4/30/2023134,500 shares $173,505.00 +163.2%0.8%4.5 $1.29 4/15/202351,100 shares $72,562.00 No Change0.3%1.6 $1.42Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/31/202351,100 shares $68,985.00 +24.3%0.3%2.4 $1.35 3/15/202341,100 shares $61,650.00 +43.7%0.3%1.5 $1.50 2/28/202328,600 shares $51,480.00 +2.1%0.2%0.8 $1.80 2/15/202328,000 shares $56,000.00 +20.7%0.2%0.8 $2.00 1/31/202323,200 shares $59,612.40 -16.6%0.2%0.6 $2.57 1/15/202327,800 shares $57,824.00 -9.5%0.2%0.5 $2.08 12/30/202230,700 shares $54,953.00 -39.8%0.3%0.6 $1.79 12/15/202251,000 shares $96,390.00 +38.6%0.6%1.2 $1.89 11/30/202236,800 shares $64,400.00 -16.0%0.4%1 $1.75 11/15/202243,800 shares $79,278.00 -6.8%0.5%1.2 $1.81 10/31/202247,000 shares $91,180.00 -2.7%0.5%1.2 $1.94 10/15/202248,300 shares $122,682.00 -16.2%0.5%1.5 $2.54 9/30/202257,600 shares $180,864.00 +12.3%0.6%3.1 $3.14 9/15/202251,300 shares $175,959.00 +4.3%0.5%3.1 $3.43 8/31/202249,200 shares $170,724.00 -5.0%0.5%3.2 $3.47 8/15/202251,800 shares $181,300.00 -9.4%0.5%3.4 $3.50 7/31/202257,200 shares $177,320.00 -8.9%0.6%4.5 $3.10 7/15/202262,800 shares $209,752.00 -9.8%0.7%3.3 $3.34 6/30/202269,600 shares $225,504.00 +8.4%0.7%1.6 $3.24 6/15/202264,200 shares $222,132.00 -29.0%0.7%1.3 $3.46 5/31/202290,400 shares $340,808.00 +49.9%1.0%1.7 $3.77 5/15/202260,300 shares $241,200.00 +14.4%0.6%1.1 $4.00 4/30/202252,700 shares $188,666.00 -27.1%0.5%1 $3.58 4/15/202272,300 shares $375,237.00 +22.3%0.7%1.3 $5.19 3/31/202259,100 shares $300,819.00 +16.8%0.6%1.6 $5.09 3/15/202250,600 shares $189,750.00 -14.0%0.5%1.4 $3.75 2/28/202258,800 shares $242,256.00 +19.5%0.6%1.4 $4.12 2/15/202249,200 shares $233,208.00 -2.4%0.5%1.2 $4.74 1/31/202250,400 shares $216,216.00 +12.0%0.5%1.1 $4.29 1/15/202245,000 shares $281,250.00 -15.3%0.4%1 $6.25 12/31/202153,100 shares $415,242.00 +46.3%0.5%1.3 $7.82 12/15/202136,300 shares $265,353.00 -13.4%0.4%0.7 $7.31 11/30/202141,900 shares $434,084.00 -13.6%0.4%0.6 $10.36 11/15/202148,500 shares $485,485.00 -38.0%0.5%0.5 $10.01 10/29/202178,200 shares $878,186.00 +18.3%0.8%0.7 $11.23 10/15/202166,100 shares $649,763.00 -27.0%0.6%0.4 $9.83 9/30/202190,600 shares $982,104.00 -34.4%0.9%0.5 $10.84 9/15/2021138,200 shares $1.15 million +128.8%1.4%0.7 $8.32 8/31/202160,400 shares $485,616.00 +571.1%0.6%0.3 $8.04 8/13/20219,000 shares $68,310.00 No Change0.1%0 $7.59 CADL Short Interest - Frequently Asked Questions What is Candel Therapeutics' current short interest? Short interest is the volume of Candel Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 2,180,000 shares of CADL short. 10.86% of Candel Therapeutics' shares are currently sold short. Learn More on Candel Therapeutics' current short interest. What is a good short interest ratio for Candel Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CADL shares currently have a short interest ratio of 6.0. Learn More on Candel Therapeutics's short interest ratio. Which institutional investors are shorting Candel Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Candel Therapeutics: Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Candel Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.86% of Candel Therapeutics' floating shares are currently sold short. Is Candel Therapeutics' short interest increasing or decreasing? Candel Therapeutics saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 2,180,000 shares, an increase of 3.8% from the previous total of 2,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Candel Therapeutics' float size? Candel Therapeutics currently has issued a total of 32,476,000 shares. Some of Candel Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Candel Therapeutics currently has a public float of 20,080,000 shares. How does Candel Therapeutics' short interest compare to its competitors? 10.86% of Candel Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Candel Therapeutics: Ardelyx, Inc. (10.27%), ARS Pharmaceuticals, Inc. (26.75%), Rocket Pharmaceuticals, Inc. (11.40%), Bicycle Therapeutics plc (4.91%), Avadel Pharmaceuticals plc (10.16%), Anavex Life Sciences Corp. (23.22%), Collegium Pharmaceutical, Inc. (19.63%), Poseida Therapeutics, Inc. (4.20%), Nuvation Bio Inc. (6.17%), ArriVent BioPharma, Inc. (17.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Candel Therapeutics stock? Short selling CADL is an investing strategy that aims to generate trading profit from Candel Therapeutics as its price is falling. CADL shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Candel Therapeutics? A short squeeze for Candel Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CADL, which in turn drives the price of the stock up even further. How often is Candel Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CADL, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies ARDX Short Interest SPRY Short Interest RCKT Short Interest BCYC Short Interest AVDL Short Interest AVXL Short Interest COLL Short Interest PSTX Short Interest NUVB Short Interest AVBP Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CADL) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Candel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CADL Stock Alerts